Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: J Allergy Clin Immunol. 2010 Nov 4;126(6):1149–56.e1. doi: 10.1016/j.jaci.2010.08.049

Table III.

Baseline Characteristics of SARP Participants who enrolled at Age of 40 Years and above by Racial Background & Phenotype Group

Both Races
N=398
Black
n=105 (26.4%)
White
n=293 (73.4%)




Mild/Mod
n=166
Severe
n=232
Mild/Mod
n=45
Severe
n=60
Mild/Mod
n=121
Severe
n=172




*Age at Diagnosis (yrs) 18(5,36) 20(5.5,35) 18(5,35) 13(3.5,33.5) 18(6,38) 21(6.5,35)
Duration of Asthma (yrs) 31.6(11.2,42.3) 29.9(15.8,45.3) 25.9(11.2,39.6) 31.9(15.3,43.5) 32(11.2,42.7) 29.4(16.5,46.4)
*BMI (kg/m2) 29.1(25.8,34.9) 30.8(26,35.2) 32.9(28.3,38.2) 32.9(26.9,36.9) 28.4(24.6,32.9) 30(25.8,34.3)
Baseline Predrug FEV1 (liters) 2.31(1.81,2.73) 1.74(1.26,2.26) 1.84(1.69,2.31) 1.71(1.30,2.18) 2.45(2.00,2.89) 1.77(1.24,2.34)
*Baseline Predrug FEV1% Pred 78(66,87) 57(44,75) 73(57,86) 64.5(48.5,85.5) 79(66,88) 56(42,71)
*Baseline Predrug FVC% Pred 85(76,94) 73.6(60,84) 83(72.3,91) 79(66.8,97) 86(77,94) 72(58,82)
*FEV1/FVC 0.73(0.65,0.78) 0.65(0.54,0.72) 0.73(0.64,0.76) 0.67(0.3,0.72) 0.72(0.66,0.78) 0.63(0.53,0.72)
Max FEV1 Reversal (%) 11.5(7.1,20.2) 13.8(6.3,24.5) 13.1(6.8,20.7) 15.4(7.5,25.7) 11(7.1,19.4) 13.7(6,24)
*Log IgE (IU/ml) 1.94(1.46,2.36) 2.00(1.44,2.49) 2.14(1.73,2.64) 2.29(1.83(2.72) 1.90(1.43,2.31) 1.93(1.34,2.36)
Atopy 122(73.5%) 136(58.6%) 33(73.3%) 34(56.7%) 89(73.6%) 102(59.3%)
5 Positive Skin Tests 44(26.5%) 40(17.2%) 16(35.6%) 12(20%) 28(23.1%) 28(16.3%)
*Female 107(64.5%) 148(63.8%) 30(66.7%) 44(73.3%) 77(63.6%) 104(60.5%)
Currently Employed 125(75.3%) 144(62.1%) 30(66.7%) 33(55%) 95(78.5%) 111(64.5%)
Diagnosed Diabetes 12(7.2%) 31(13.4%) 3(6.7%) 9(15%) 9(15%) 22(12.8%)
Diagnosed Hypertension 37(22.3%) 72(31%) 13(28.9%) 19(31.7%) 19(31.7%) 53(30.8%)
*Diagnosed GERD 49(29.5%) 98(42.4%) 12(26.7%) 20(33.3%) 37(30.6%) 78(45.3%)
*

Mean age: 51.3 ± 7.86

Continuous variables: median (25th, 75th percentiles); Categorical variables: n (%)

FEV1: forced expiratory volume in one second

FVC: forced vital capacity ratio

GERD: gastroesophageal reflux disease.

2ndhand smoke exp: secondhand smoke exposure

*

p < 0.15 Black severe vs White severe.